Democratic Party Finds Samba: "We Will Support the Korea-US Vaccine Partnership"

Opening of the Highest-Level On-Site Meeting at Songdo 2 Plant

[Image source=Yonhap News]

[Asia Economy Reporter Jeon Jinyoung] The Democratic Party of Korea held an executive committee meeting at Samsung Biologics, which produces COVID-19 vaccines. This is interpreted as an effort to share the achievements of the Korea-US summit and to project a ‘pro-business’ image. Previously, Lee Jae-myung, the ruling party's presidential candidate and Governor of Gyeonggi Province, visited the Hyundai Motor and Kia Technology Research Center, and former Prime Minister Chung Sye-kyun also visited Samsung Biologics.

Song Young-gil, leader of the Democratic Party, held an on-site executive committee meeting at Samsung Biologics Plant 2 in Songdo, Incheon, in the morning and said, "We will actively support the concretization of the global vaccine partnership agreed upon by President Moon Jae-in and U.S. President Joe Biden during the summit." The company has signed a contract to manufacture Moderna's COVID-19 vaccine on consignment.

Yoon Ho-jung, floor leader, also praised, "Through the Korea-US summit, South Korea has laid the foundation to leap forward as a global vaccine production hub," adding, "When good companies and good politics meet, such achievements are possible."

John Rim, CEO of Samsung Biologics, said, "This (Moderna) contract is the result of the ruling party and government’s full support for ‘K-Bio’," and added, "We will actively collaborate with the government and Moderna to restore our status as the most exemplary country in early COVID-19 eradication."

This content was produced with the assistance of AI translation services.